The startup's Cordella Pulmonary Artery Pressure Sensor System, which was implanted in 70 heart failure patients in Europe, led to low hospitalization rates and high patient compliance with daily measurements needed to monitor them remotely.
While Endotronix's care management software platform was cleared for the market very quickly, FDA officials are taking the opposite approach when it comes to approving the company's implantable, wireless pulmonary artery pressure sensor.
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.
CardioCell's in Phase 2a trials with its stem cell therapy for chronic heart failure. Its approach is to infuse stem cells into a patient's system taht stimulate the heart cells into to working again.
Chronic heart failure is a condition that affects 5.7 million people in the U.S. and about 670,000 new patients are diagnosed each year. A couple of medical school professors at the University of Pennsylvania are taking an innovative approach to developing a treatment that focuses on how the heart uses energy in a treatment area […]